ميكلوفينوكسات

Meclofenoxate is broken down by the liver into DMAE and PCPA (parachlorphenoxyacetic acid). It has been shown to cause mild memory improvement in people with dementia and has been marketed as an anti-aging supplement.

Also known as: أسيفين, لوكيدريل, سنتروفينوكسين

Classification

Psychoactive: Nootropic
Psychoactive: Stimulant
Tag: Cholinergic
Tag: Tentative

Effects

Increased Heart Rate
Stimulation
Insomnia
Nausea
Loss Of Appetite
Talkativeness
Alertness Enhancement
Motivation Enhancement
Euphoria
Focus Enhancement
Light Sensitivity
Appetite Suppression
Open Eye Visuals
Dehydration
Increased Libido

Routes of Administration

Oral

Dosage

Common: 250 mg 1-6 x a day
Heavy: 1000 mg
Light: 50-200 mg
Strong: 800-1000 mg

Duration

No data available for this section yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu